Todd W.  Garner net worth and biography

Todd Garner Biography and Net Worth

CFO of CONMED
TODD W. GARNER joined the Company as Executive Vice President & Chief Financial Officer on January 2, 2018. Prior to joining CONMED, he served as Vice President - Investor Relations for C.R. Bard, Inc. from 2011 until December 2017. Mr. Garner’s prior roles with C.R. Bard, Inc. include Vice President, Controller (Division Chief Financial Officer) for its Medical division from 2007 through 2011, Director of Financial Reporting from 2005 through 2007 and the Controller of the Reynosa Operations from 2003 through 2005. Prior to working at C.R. Bard, Inc., Mr. Garner was the acting CFO and Controller at Echopass Corporation (currently Genesys Corporation) from 2000 to 2003, the Controller and Value Planning Manager at Futura Industries, Corp. from 1997 to 2000, Accounting Manager at Excel Communications in 1997 and Accounting Coordinator at Verizon from 1995 to 1996. Mr. Garner began his career with Arthur Andersen LLP, where he was a senior auditor from 1992 to 1995. Mr. Garner holds an MBA from the University of Texas - Pan American, and a B.S. in accounting from Brigham Young University. Mr. Garner is also a Certified Public Accountant.

What is Todd W. Garner's net worth?

The estimated net worth of Todd W. Garner is at least $81,874.45 as of March 13th, 2023. Mr. Garner owns 1,115 shares of CONMED stock worth more than $81,874 as of November 9th. This net worth approximation does not reflect any other investments that Mr. Garner may own. Additionally, Mr. Garner receives an annual salary of $1,170,000.00 as CFO at CONMED. Learn More about Todd W. Garner's net worth.

How old is Todd W. Garner?

Mr. Garner is currently 55 years old. There are 8 older executives and no younger executives at CONMED. The oldest executive at CONMED is Mr. David R. Murray, President of ConMed Electrosurgery, who is 76 years old. Learn More on Todd W. Garner's age.

What is Todd W. Garner's salary?

As the CFO of CONMED Co., Mr. Garner earns $1,170,000.00 per year. There are 2 executives that earn more than Mr. Garner. The highest earning executive at CONMED is Mr. Curt R. Hartman, Chairman of the Board, CEO & President, who commands a salary of $2,450,000.00 per year. Learn More on Todd W. Garner's salary.

How do I contact Todd W. Garner?

The corporate mailing address for Mr. Garner and other CONMED executives is 525 FRENCH ROAD, UTICA NY, 13502. CONMED can also be reached via phone at (727) 392-6464. Learn More on Todd W. Garner's contact information.

Has Todd W. Garner been buying or selling shares of CONMED?

Todd W. Garner has not been actively trading shares of CONMED in the last ninety days. Learn More on Todd W. Garner's trading history.

Who are CONMED's active insiders?

CONMED's insider roster includes Pat Beyer (Insider), Brian Concannon (Director), Todd Garner (CFO), Curt Hartman (CEO), Daniel Jonas (Insider), John Kennedy (EVP), Stanley Peters, III (VP), Peter Shagory (EVP), and Mark Tryniski (Director). Learn More on CONMED's active insiders.

Are insiders buying or selling shares of CONMED?

In the last twelve months, CONMED insiders bought shares 3 times. They purchased a total of 6,442 shares worth more than $446,732.92. In the last twelve months, insiders at the sold shares 2 times. They sold a total of 6,300 shares worth more than $540,119.00. The most recent insider tranaction occured on June, 14th when insider Stanley W Peters III sold 4,000 shares worth more than $287,280.00. Insiders at CONMED own 6.8% of the company. Learn More about insider trades at CONMED.

Information on this page was last updated on 6/14/2024.

Todd W. Garner Insider Trading History at CONMED

See Full Table

Todd W. Garner Buying and Selling Activity at CONMED

This chart shows Todd W. Garner's buying and selling at CONMED by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CONMED Company Overview

CONMED logo
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Read More

Today's Range

Now: $73.43
Low: $73.27
High: $76.78

50 Day Range

MA: $69.63
Low: $61.80
High: $76.93

2 Week Range

Now: $73.43
Low: $61.05
High: $117.27

Volume

464,114 shs

Average Volume

445,614 shs

Market Capitalization

$2.27 billion

P/E Ratio

17.44

Dividend Yield

1.07%

Beta

1.45